145 related articles for article (PubMed ID: 8115983)
1. Haemostatic variables and menopausal status: influence of hormone replacement therapy.
Scarabin PY; Plu-Bureau G; Bara L; Bonithon-Kopp C; Guize L; Samama MM
Thromb Haemost; 1993 Oct; 70(4):584-7. PubMed ID: 8115983
[TBL] [Abstract][Full Text] [Related]
2. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolysis and lipoprotein(a) in women with coronary artery disease. Influence of hormone replacement therapy.
Falcó C; Tormo G; Estellés A; España F; Tormo E; Gilabert J; Velasco JA; Aznar J
Haematologica; 2001 Jan; 86(1):92-8. PubMed ID: 11146577
[TBL] [Abstract][Full Text] [Related]
4. Effect of hormone replacement therapy on hemostatic variables in post-menopausal women.
Al-Farra HM; Al-Fahoum SK; Tabbaa MA
Saudi Med J; 2005 Dec; 26(12):1930-5. PubMed ID: 16380775
[TBL] [Abstract][Full Text] [Related]
5. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
6. The effects of hormone replacement therapy on antithrombin III and protein C levels in menopausal women.
Lacroix KA; Bean C; Reilly R; Curran-Celentano J
Clin Lab Sci; 1997; 10(3):145-8. PubMed ID: 10167774
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
8. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
10. Influence of hormone replacement therapy on blood antioxidant enzymes in menopausal women.
Unfer TC; Conterato GM; da Silva JC; Duarte MM; Emanuelli T
Clin Chim Acta; 2006 Jul; 369(1):73-7. PubMed ID: 16472795
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
Windler E; Zyriax BC; Eidenmüller B; Boeing H
Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
[TBL] [Abstract][Full Text] [Related]
12. [Hormone replacement therapy of menopause, heart and blood vessels].
Kuttenn F; Gerson M
Arch Mal Coeur Vaiss; 2001 Jul; 94(7):685-9. PubMed ID: 11494629
[TBL] [Abstract][Full Text] [Related]
13. Effect of the cessation of long-term hormone replacement therapy on plasma plasminogen activator inhibitor-1 and fibrinogen.
Kalela A; Jokela H; Lehtimäki T; Uppa H; Kunnas T; Teisala K; Punnonen R; Nikkari ST
Eur J Obstet Gynecol Reprod Biol; 2006 Apr; 125(2):217-20. PubMed ID: 16337074
[TBL] [Abstract][Full Text] [Related]
14. The effects of postmenopausal hormone replacement therapy on hemostatic variables: a meta-analysis of 46 studies.
Acs N; Vajo Z; Miklos Z; Siklosi G; Paulin F; Felicetta JV; Székåcs B
Gynecol Endocrinol; 2002 Aug; 16(4):335-46. PubMed ID: 12396563
[TBL] [Abstract][Full Text] [Related]
15. [Influence of estrogen replacement therapy on atherogenic profile in postmenopausal women].
Alfonso Cano C; Vez García MD; García Urruticoechea P; Tornel Osorio PL; Canteras Jordana M; Abellán Alemán J
An Med Interna; 2003 Feb; 20(2):70-4. PubMed ID: 12703158
[TBL] [Abstract][Full Text] [Related]
16. [Menopause and hormone replacement therapy (HRT) in women with diabetes].
Cyganek K
Przegl Lek; 1999; 56(5):362-71. PubMed ID: 10554574
[TBL] [Abstract][Full Text] [Related]
17. [Monitoring the breast changes of Chinese postmenopausal women under long-term hormone replacement therapy by mammary ultrasonography].
Huang MT; Jiang YX; Lin SQ; Zhang Y; Zhou YZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):24-9. PubMed ID: 15052769
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy (HRT) and ischaemic heart disease: getting to the heart of the matter.
Chew S; Ng SC
Singapore Med J; 2002 Jan; 43(1):41-4. PubMed ID: 12008777
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
Rosano GM; Vitale C; Fini M
Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
[TBL] [Abstract][Full Text] [Related]
20. Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI and C-reactive protein--a cross-sectional population survey.
Lowe GD; Upton MN; Rumley A; McConnachie A; O'Reilly DS; Watt GC
Thromb Haemost; 2001 Aug; 86(2):550-6. PubMed ID: 11522002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
